(Pyrimidin-5-yl)boronic acid → HCID 67977264, compound
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([CH:14]2[O:23][C:17]3=[CH:18][N:19]=[C:20](Cl)[CH:21]=[C:16]3[CH2:15]2)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[N:24]1[CH:29]=[C:28](B(O)O)[CH:27]=[N:26][CH:25]=1>>[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][CH:11]([CH:14]2[O:23][C:17]3=[CH:18][N:19]=[C:20]([C:28]4[CH:29]=[N:24][CH:25]=[N:26][CH:27]=4)[CH:21]=[C:16]3[CH2:15]2)[CH2:10][CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2]Participants
3
Procedure
The title compound is prepared from 4-(5-chloro-2,3-dihydro-furo[2,3-c]pyridin-2-yl)-piperidine-1-carboxylic acid tert-butyl ester and pyrimidine-5-boronic acid following a procedure analogous to that described in Example 28. LC (method 7): tR=1.38 min; Mass spectrum (ESI+): m/z=383 [M+H]+.
Sources & evidence
- ORD record
- ord-cf5e25e6a8094b49b3ba4cd8b765508b
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08669271B2
Reaction notes
Loading…